Page 2 - White Paper on Experimental Vaccines for Covid-19*

America’s Frontline Doctors White Paper On

Experimental Vaccines For COVID-19

TABLE OF CONTENTS

Executive Summary……………………………………………………………..……….1

FAQs………………………………………………………………………………………2

I. COVID-19: Policy Myths……………………………………………………………….4

II. COVID-19 Medical Myths: Low Infection Fatality Ratio (IFR)……………………..10

III. COVID-19 Experimental Vaccines Trials……………………...……………………11

IV. COVID-19 Experimental Vaccines Controversies…………………………………..13

Brand New Technology
Failure of Previous Coronavirus Vaccines
No Ani mal Studies
Known Complications
Unknown Complications
Pharmaceutical Companies are Immune from All Liability
An Experimental Vaccine is Not Safer than a Very Low IFR
No Proof the Vaccine Stops Transmission of the Virus
Unknown Mortality or Hospital Admission Benefit
The Vaccine Lasts Unknown Duration
The Data Has Not Been Independently Peer-Reviewed & Published

V. EXPERIMENTAL COVID-19 Vaccines………………...……………………….….17

VI. COVID-19 Experimental Vaccines & Antibody- Enhancement…………………….18

VII. COVID-19 Experimental Vaccines & Other Known Problems…………………….21

VIII. COVID-19 Experimental Vaccines & Other Unknown or New Problems………..23

IX. Pharmaceutical Companies Conflict of Interests………………………………….…25

X. Experimental Vaccines & Legal Issues for Patients .………………………………...25

XI. COVID-19 Experimental Vaccines & Unusual Processes…..………………………27

XII. AFLDS Recommendations Regarding Experimental Covid-19 Vaccines……….…32

XIII. Call To Action…………………………………………………………………...…33